Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells

Kidney International

Volumn 51, Issue 4, 1997, Pages 1245-1256

  Van Setten, Petra A ^b   Van Hinsbergh, Victor W M ^b   Van Der Velden, Thea J A N ^b   Van De Kar, Nicole C A J ^b   Vermeer, Mario ^b   Mahan, John D ^b   Assmann, Karel J M ^b   Van Den Heuvel, Lambertus P W J ^b   Monnens, Leo A H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GLOMERULUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030935633     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.170     Document Type: Article

References (58)

1. FONG JS, DE CHADAREVIAN JP, KAPLAN BS: Hemolytic uremic syndrome. Current concepts and management. Pediatr Clin N Am 29:835-856, 1982
2. RICHARDSON SE, KARMALI MA, BECKER LE, SMITH CR: The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19:1102-1108, 1988
3. KARMALI MA, PETRIC M, LIM C, FLEMING DC, ARBUS GS, LIOR H: The association between idiopathic hemolytic syndrome and infection by verocytotoxin producing Escherichia coli. J Infect Dis 151:775-782, 1985
4. TESH VL, SAMUEL JE, PERERA LP, SHAREFKIN JB, O'BRIEN AD: Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352, 1991
5. LOUISE CB, OBRIG TG: Shiga toxin-associated hemolytic-uremic syndrome: Combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59:4173-4179, 1991
6. VAN DE KAR NC, MONNENS LA, KARMALI MA, VAN HINSBERGH VW: Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764, 1992
7. KAYE SA, LOUISE CB, BOYD B, LINGWOOD CA, OBRIG TG: Shiga toxin-associated hemolytic uremic syndrome: Interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 61:3886-3891, 1993
8. HEWETT PW, MURRAY JC: Human microvessel endothelial cells: Isolation, culture and characterization. In Vitro Cell Dev Biol Anim 29A:823-830, 1993
9. GIBBS VC, WOOD DM, GAROVOY MR: The response of cultured human kidney capillary endothelium to immunologic stimuli. Hum Immunol 14:259-269, 1985
10. STRIKER GE, SODERLAND C, BOWEN-POPE DF, GOWN AM, SCHMER G, JOHNSON A, LUCHTEL D, ROSS R, STRIKER LJ: Isolation, characterization, and propagation in vitro of human glomerular endothelial cells. J Exp Med 160:323-328, 1984
11. BALLERMANN BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 256:C182-C189, 1989
12. GREEN DF, HWANG KH, RYAN US, BOURGOIGNIE JJ: Culture of endothelial cells from baboon and human glomeruli. Kidney Int 41:1506-1516, 1992
13. OBRIG TG, LOUISE CH, LINGWOOD CA, BOYD B, BARLEY-MALONEY L, DANIEL TO: Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484-15488, 1993
14. MACIAG T, CERUNDOLO J, ILSLEY S, KELLEY PR, FORAND R: An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 76:5674-5678, 1979
15. CUI YC, TAI PC, GATTER KC, MASON DY, SPRY CJ: A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues. Immunology 49:183-189, 1983
16. LAMPUGNANI MG, RESNATI M, RAITERI M, PIGOTT R, PISACANE A, HOUEN G, RUCO LP, DEJANA E: A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118:1511-1522, 1992
17. VAN MUIJEN GN, RUITER DJ, WARNAAR SO: Coexpression of intermediate filament polypeptides in human fetal and adult tissues. Lab Invest 57:359-369, 1987
18. LEEUWENBERG JF, JEUNHOMME TM, BUURMAN WA: Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol 35:335-341, 1992
19. SALACINSKI PR, MCLEAN C, SYKES JE, CLEMENT-JONES VV, LOWRY PJ: Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem 117:136-146, 1981
20. SCATCHARD G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672, 1946
21. NUDELMAN E, KANNAGI R, HAKOMORI S, PARSONS M, LIPINSKI M, WIELS J, FELLOUS M, TURSZ T: A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220: 509-511, 1983
22. LINGWOOD CA, LAW H, RICHARDSON S, PETRIC M, BRUNTON JL, DE-GRANDIS S, KARMALI M: Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262:8834-8839, 1987
23. STERZEL RB, LOVETT DH, FOELLMER HG, PERFETTO M, BIEMESDERFER D, KASHGARIAN M: Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 125:130-140, 1986
24. DETRISAC CJ, SENS MA, GARVIN AJ, SPICER SS, SENS DA: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25:383-390, 1984
25. MORAN T, LINGWOOD C, BRANCA A, DEL VECCHIO P, BROWN J, OBRIG T: Analysis of shiga toxin receptors on human vascular endothelial cells. Abstract Annual Meeting of the American Society of Microbiology 46:B93, 1989
26. COHEN A, MADRID-MARINA V, ESTROV Z, FREEDMAN MH, LINGWOOD CA, DOSCH HM: Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: A mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol 2:1-8, 1990
27. BOYD B, LINGWOOD C: Verotoxin receptor glycolipid in human renal tissue. Nephron 51:207-210, 1989
28. OBRIG TG, MORAN TP, BROWN JE: The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244:287-294, 1987
29. HANCOCK WW, COTRAN RS: Induction of activation antigens on human glomerular endothelium by interleukin 1, interferon-γ and endotoxin. (abstract) Kidney Int 31:322, 1987
30. COTRAN RS, POBER JS: Effects of cytokines on vascular endothelium: Their role in vascular and immune injury. Kidney Int 35:969-975, 1989
31. REDL H, DINGES HP, BUURMAN WA, VAN DER LINDEN CJ, POBER JS, COTRAN RS, SCHLAG G: Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. Am J Pathol 139:461-466, 1991
32. NIKOLIC-PATERSON DJ, YU Y, ATKINS RC: Regulation of glomerular vcam-1 and elam-1 gene expression by inflammatory stimuli. (abstract) J Am Soc Nephrol 3:639, 1992
33. BRISCOE DM, COTRAN RS: Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: In vitro and in vivo studies. Kidney Int 44:(Suppl 42):S27-S34, 1993
34. OTT MJ, OLSON JL, BALLERMANN BJ: Phenotypic differences between glomerular capillary (GE) and aortic (AE) endothelial cells in vitro. (abstract) J Am Soc Nephrol 4:564, 1993
35. OBRIG TG, DEL-VECCHIO PJ, BROWN JE, MORAN TP, ROWLAND BM, JUDGE TK, ROTHMAN SW: Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373-2378, 1988
36. PUDYMAITIS A, LINGWOOD CA: Susceptibility to verotoxin as a function of the cell cycle. J Cell Physiol 150:632-639, 1992
37. HOBSON B, DENEKAMP J: Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br J Cancer 49:405-413, 1984
38. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 24:626-631, 1983
39. JACKSON MP, NEWLAND JW, HOLMES RK, O'BRIEN AD: Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog 2:147-153, 1987
40. LOUISE CB, OBRIG TG: Specific interaction of Escherichia coli O157: H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397-1401, 1995
41. STROCKBINE NA, MARQUES LR, NEWLAND JW, SMITH HW, HOLMES RK, O'BRIEN AD: Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53:135-140, 1986
42. WADDELL T, HEAD S, PETRIC M, COHEN A, LINGWOOD C: Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun 152:674-679, 1988
43. HEAD SC, KARMALI MA, LINGWOOD CA: Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem 266:3617-3621, 1991
44. TESH VL, BURRIS JA, OWENS JW, GORDON VM, WADOLKOWSKI EA, O'BRIEN AD, SAMUEL JE: Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392-3402, 1993
45. HAREL Y, SILVA M, GIROIR B, WEINBERG A, CLEARY TB, BEUTLER B: A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest 92:2110-2116, 1993
46. TESH VL, RAMEGOWDA B, SAMUEL JE: Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62:5085-5094, 1994
47. VAN SETTEN PA, MONNENS LAH, VERSTRATEN RGG, VAN DEN HEUVEL LPWJ, VAN HINSBERGH VWM: Effects of verocytotoxin-1 on nonadherent human monocytes: Binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183, 1996
48. FITZPATRICK MM, SHAH V, TROMPETER RS, DILLON MJ, BARRATT TM: Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42:951-956, 1992
49. SIEGLER RL, EDWIN SS, CHRISTOFFERSON RD, MITCHELL MD: Plasma and urinary cytokines in childhood hemolytic uremic syndrome. (abstract) J Am Soc Nephrol 2:274, 1991
50. KARPMAN D, ANDREASSON A, THYSELL H, KAPLAN BS, SVANBORG C: Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 9:694-699, 1995
51. VAN DE KAR NCAJ, SAUERWEIN RW, DEMACKER PNM, GRAU GE, VAN HINSBERGH VWM, MONNENS LAH: Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309-313, 1995
52. ABBOTT F, TAM FW, RYAN JJ, REES AJ: Human mesangial cells synthesize interleukin 1 alpha but not interleukin 1 beta, interleukin 1 receptor antagonist, or tumor necrosis factor. Nephrol Dial Transplant 7:997-1001, 1992
53. ABBOTT F, RYAN JJ, CESKA M, MATSUSHIMA K, SARRAF CE, REES AJ: Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int 40:597-605, 1991
54. VON ASMUTH EJ, DENTENER MA, CESKA M, BUURMAN WA: IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. Eur Cytokine Netw 5:301-310, 1994
55. LINGWOOD CA: Verotoxin-binding in human renal sections. Nephron 66:21-28, 1994
56. BUSTOS C, GONZALEZ E, MULEY R, ALONSO JL, EGIDO J: Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 24:799-805, 1994
57. TAKEMURA T, YOSHIOKA K, MURAKAMI K, AKANO N, OKADA M, AYA N, MAKI S: Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 424:459-464, 1994
58. SAXENA S, MITTAL A, ANDAL A: Pattern of interleukins in minimal-change nephrotic syndrome of childhood. Nephron 65:56-61, 1993